Sort   by:  
 Page size 
UnknownComplete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Not available
S-EPMC4872006 | biostudies-literature
UnknownMatching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma.
Not available
S-EPMC11881270 | biostudies-literature
UnknownClinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.
Not available
S-EPMC5904008 | biostudies-literature
UnknownIdentifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma.
Not available
S-EPMC10514205 | biostudies-literature
UnknownTafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
Not available
S-EPMC10797539 | biostudies-literature
UnknownImpact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL.
Not available
S-EPMC11318327 | biostudies-literature
UnknownLong-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma.
Not available
S-EPMC7907727 | biostudies-literature
UnknownImpact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy.
Not available
S-EPMC9904360 | biostudies-literature
UnknownVenetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study.
Not available
S-EPMC6158762 | biostudies-literature
UnknownA prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
Not available
S-EPMC9284943 | biostudies-literature
Sort   by:  
 Page size